£90,000 ‘Breakthrough’ Alzheimer’s Drugs Under Fire: New Report Says Benefits May Be Minimal Read more about £90,000 ‘Breakthrough’ Alzheimer’s Drugs Under Fire: New Report Says Benefits May Be Minimal Read More